| VEGFA |
P15692
|
vascular endothelial growth factor A
|
Signaling
|
2.4E-05 |
0.266 |
0.923 |
| CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
| COMT |
P21964
|
catechol-O-methyltransferase
|
Enzyme
|
1.1E-06 |
0.400 |
0.923 |
| GSTT1 |
P30711
|
glutathione S-transferase theta 1
|
|
1.5E-04 |
0.393 |
0.923 |
| CYP2D6 |
P10635
|
cytochrome P450 family 2 subfamily D member 6
|
|
1.1E-25 |
0.437 |
0.885 |
| SLC6A3 |
Q01959
|
solute carrier family 6 member 3
|
Transporter
|
1.00 |
0.453 |
0.885 |
| NRG1 |
Q02297
|
neuregulin 1
|
Signaling
|
1.00 |
0.464 |
0.885 |
| HTR2A |
P28223
|
5-hydroxytryptamine receptor 2A
|
G-protein coupled receptor
|
0.51 |
0.473 |
0.846 |
| C9orf72 |
Q96LT7
|
C9orf72-SMCR8 complex subunit
|
|
1.1E-06 |
0.496 |
0.769 |
| ACACA |
Q13085
|
acetyl-CoA carboxylase alpha
|
|
1.00 |
0.480 |
0.846 |
| SELENBP1 |
Q13228
|
selenium binding protein 1
|
Immune response
|
3.2E-16 |
0.493 |
0.846 |
| BMS1 |
Q14692
|
BMS1 ribosome biogenesis factor
|
|
1.8E-04 |
0.499 |
0.846 |
| DRD4 |
P21917
|
dopamine receptor D4
|
G-protein coupled receptor
|
9.3E-09 |
0.517 |
0.577 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| DISC1 |
Q9NRI5
|
DISC1 scaffold protein
|
|
1.7E-06 |
0.548 |
0.769 |
| HTR4 |
Q13639
|
5-hydroxytryptamine receptor 4
|
G-protein coupled receptor
|
2.5E-02 |
0.610 |
0.615 |
| LOC107987479 |
|
cytochrome P450 2D6
|
|
|
0.597 |
0.769 |
| HTR3A |
P46098
|
5-hydroxytryptamine receptor 3A
|
Ion channel
|
1.7E-10 |
0.608 |
0.538 |
| ECT |
|
centralopathic epilepsy
|
|
|
0.626 |
0.423 |
| CYP2D7 |
A0A087X1C5
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)
|
|
|
0.659 |
0.577 |
| PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
| ADRA2C |
P18825
|
adrenoceptor alpha 2C
|
G-protein coupled receptor
|
0.50 |
0.682 |
0.346 |
| BLVRB |
P30043
|
biliverdin reductase B
|
Enzyme
|
4.2E-06 |
0.695 |
0.423 |